SEARCH 
COMPANIES
Discover the reality of companies and brands!
TRANSNATIONALE.ORG
Free and independant information on large corporations

DSM NV

Headquarters : P.O. Box 6500 6410 JH Heerlen Netherlands Netherlands web www.dsm.nl tel. 31455788111 stock : DSMKY analytics


Brands

name
click to compare prices
» Shop local, ethical and at the best price on Ethishop

« Ethical » rating of DSM NV , group and subsidiaries

Jobs -12% /1998 Sales 8 Bn $.€ /year Profit 4 Bn $.€ /1998 Influence 5
[click on the rating for the method or on the number for the data]

shareholdercountry%source
ABN Amro Holding NVNetherlands5,08
Aegon NVNetherlands6,31
Commercial UnionUnited Kingdom8,7
» More shareholders of DSM NV

  • Environmental impact

  • Human impact

year name
photo position; compensation
source
2000Dopper, J G
See the photo of: Dopper, J G Director;
Corporate Europe Observatory
2000Wijffels, Herman H
See the photo of: Wijffels, Herman H Chairman of the Monitoring Committee;
1999Bree, De
See the photo of: Bree, De Chairman;
year
employees
<>
social impact : country
source
2005
-350
Closure/Bankruptcy: Closes down production of bulk vitamin C in the US and cuts costs at its plant in Dalry, Scotland:
Nutra-ingredients USA
2004
-420
Le Bulletin des agriculteurs
2004
24180
-290
Internal restructuring: Germany
2004
-400
Relocation: Will restructure its money-losing anti-infectives business, closing capacity in Europe and increasing output in Asia. 13% of the business's total will go. Weak markets, the decline of the dollar, and strong growth in Asia are cited as main reasons for the restructuring. A plant at Delft and a plant at Geleen, the Netherlands, will close in 2005. A joint venture with Glaxo SmithKline at Irvine, UK is to end in 2005. DSM is to expand and upgrade production at its anti-infectives plant at Toansa, India, and at its joint venture's at Harbin, Zhang Jiakou, and Zibo, China. The restructuring should mean annualized cost savings of tens of millions of euros within two years.:
European Restructuring Monitor
2004
-39
Internal restructuring:
Edicom
2004
-500
Internal restructuring: Netherlands
Les Echos
2003
-200
AP
2002
18375
2002
-100
AP
2000
2000
-1000
AP

  • Subsidy

  • Advertising & marketing

year  salesincome source
2004   7,750,26   billion Eu€
2003   6,050,14   billion Eu€
2002   6,661,19   billion Eu€
2001   7,971,42   billion Eu€
2000   8,090,58   billion Eu€
1999   6,330,37   billion Eu€
yearfinancial misdemeanorsalesincomeassetsbuybacksource
 6 informations, access to subscribers
year
purpose : intermediary/lobby : institution
source
2004Prevent binding environmental regulations (environmental protection through economic growth, self-regulation and free trade) : WBCSD (World Business Council for Sustainable Development) : : United Nations translateWBCSD
2002Market admission for genetically modified organisms : Europabio : : European Commission translateCorporate Europe Observatory
2000Market access (through WTO), cheaper energy (through energy liberalization in Europe); uniform rules to enable the patenting of plants and animals (through TRIPS); prevent advert legislation on chemicals, self-regulation instead; : CEFIC (European Chemical Industry Council) : : European Commission translateCorporate Europe Observatory
1999Deregulation and "maximum liberalization" through WTO, GATS : TABD (Transatlantic Business Dialogue) : : US Government / European Commission translateCorporate Europe Observatory
1999Market access and investment protection (through WTO, GATS), avoid social and environmental rules : ICC (International Chamber of Commerce) : : WTO, GATS translateCorporate Europe Observatory
year
purpose : intermediary/lobby : institution
source
 5 informations, access to subscribers


Bookmark and Share    en español  en français  in italiano
translate this page in arabic chinese dutch german japanese korean russian
Legal notice © T&C 1999-2010
 CONTRIBUTIONS